Dr. Irteza Bin Inayat, MD

Dr. Inayat practices at Adventhealth Diabetes Institute Orlando - HOPD in Orlando, Florida.

Dr. Inayat's NPI, 1063689339, was assigned on May 14, 2008. Dr. Inayat graduated from King Edward Medical University in 2001. Dr. Inayat holds Florida license ME104452.

Dr. Inayat's primary practice is Adventhealth Diabetes Institute Orlando - HOPD, at 2415 N Orange Ave, Orlando, FL 32804.

Dr. Inayat's primary practice is Adventhealth Diabetes Institute Orlando - HOPD in Orlando, Florida. Dr. Inayat is also affiliated with AdventHealth Orlando. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Inayat to 1 more group practice or clinic, named with a free account. Dr. Inayat's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Inayat practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Inayat's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Inayat is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Inayat's licenses on file in 2 states: Florida and Connecticut.

Dmand AI lists acid reflux, colonoscopy, gastrointestinal bleeding, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Inayat treats.

CMS data shows 453 Medicare services from Dr. Inayat across 10 procedure codes in 2024, for 264 Medicare patients. Medicare paid $27,825 for them.

CMS counts 264 Medicare patients who saw Dr. Inayat in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Inayat's median patient age at 60, with 63% women.

In 2024, Dr. Inayat wrote 212 Medicare Part D claims for 93 patients. 89% of them were for generic drugs. CMS names the drug for 130 of them, across 5 drugs with 11 or more claims each, at $3,586 in total drug cost. In 2023, CMS named 110 claims across 6 drugs.

Dr. Inayat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Inayat as offering telehealth. CMS counts 117 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Inayat, more than 80% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Inayat, published from 2010 to 2025. 2024 was the busiest year, with 3. The most frequent topics are Apoptosis, Mice, Inbred C57BL and Ascites. Dr. Inayat has published most often in Clin Gastroenterol Hepatol. Dr. Inayat's most frequent co-authors are Dennis J. Yang, MD, Aimen Farooq, MD and Muhammad K. Hasan, MD.

CMS Open Payments shows 116 general payments to Dr. Inayat from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Abbvie Inc. paid the most, $892.

Dr. Inayat graduated from King Edward Medical University in 2001. Dr. Inayat is a member of ACG, AGA, American Neurogastroenterology and Motility Society and International Society for Diseases of the Esophagus.

Dr. Inayat is in network with 19 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.